Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at [email protected].
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
New World Preview report finds strong top-line growth as pricing and patent headwinds build
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to…
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
New World Preview report finds strong top-line growth as pricing and patent headwinds build
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to…
東京、日本-2022年5月26日 – 製薬業界における戦略策定や事業性評価に不可欠な信頼性の高いマーケット情報及び分析を提供するEvaluate(エバリュエート本社:ロンドン)は、2022年4月に発行した希少疾病用医薬品動向レポート 「オーファンドラッグ 2022 レポート」(原文:英語)の日本語版をリリースしました。
London, UK and Boston, MA – 11 May 2022 – Evaluate, a leading provider of market intelligence and predictive analytics for the pharmaceutical industry, has today…
United under Norstella, each brand’s key solutions and expertise will help life-sciences-focused companies get answers—not just insights—from pipeline to patient
London, UK and New York, USA –21 April 2022 – Evaluate and Treehill Partners today announced that they have entered into a global strategic collaboration to combine…
LONDON, BOSTON, TOKYO (September 28, 2021) - The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of…
LONDON, BOSTON, TOKYO (August 20, 2021) – By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial…